Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002075298-25-000005
Filing Date
2025-11-12
Accepted
2025-11-12 16:17:18
Documents
1
Period of Report
2025-11-10

Document Format Files

Seq Description Document Type Size
1 form4-11122025_091112.html 4  
1 form4-11122025_091112.xml 4 5671
  Complete submission text file 0002075298-25-000005.txt   7209
Mailing Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Issuer) CIK: 0001653087 (see all company filings)

EIN.: 822933343 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ALECTOR, INC. 131 OYSTER POINT BLVD, SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address
Berkley Neil Lindsay (Reporting) CIK: 0002075298 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38792 | Film No.: 251473011